GoodRx Inc.

4.42
-0.08 (-1.78%)
At close: Mar 31, 2025, 3:59 PM
4.41
-0.34%
After-hours: Mar 31, 2025, 04:06 PM EDT

GoodRx Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
Net Income 16.39M -8.87M -32.83M -25.25M -293.62M 66.05M 43.79M
Depreciation & Amortization n/a 111.77M 54.18M 34.54M 18.43M 13.57M 9.81M
Stock-Based Compensation n/a 104.82M 120.23M 160.46M 397.29M 3.75M 1.76M
Other Working Capital n/a -12.93M -20.79M 27.95M 2.88M 168K 2.96M
Other Non-Cash Items -16.23M 18.07M 25.98M 7.98M 52.62M 10.41M 4.1M
Deferred Income Tax n/a -65.56M -497K 12.85M -10.91M -5.67M -2.43M
Change in Working Capital n/a -21.94M -20.29M -11.8M -32.46M -4.82M -11.77M
Operating Cash Flow 163K 138.29M 146.78M 178.78M 131.34M 83.29M 45.25M
Capital Expenditures n/a -55.77M -55.21M -34.46M -35.82M -5.75M -3.46M
Acquisitions n/a n/a -155.28M -144.28M -55.79M -31.31M n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies -70.35M -54.72M -34.67M -29.89M -15.27M -4.32M -2.65M
Investing Cash Flow -70.35M -55.77M -210.5M -178.73M -91.62M -37.05M -3.46M
Debt Repayment -167M -5.27M -7.03M -7.03M -7.03M -57.23M 606.88M
Common Stock Repurchased -158.84M -103.97M -101.72M -57.69M n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a -1.35B
Other Financial Acitivies -11.64M -58.15M -11.48M -23.5M -78.95M 828K 1.45B
Financial Cash Flow -337.5M -167.4M -120.23M -30.53M 905.82M -54.78M -24.73M
Net Cash Flow -223.95M -84.87M -183.94M -30.48M 945.54M -8.55M 17.06M
Free Cash Flow 163K 82.53M 91.57M 144.32M 95.52M 77.54M 41.8M